Vivalis opened a new R&D facility in Saint-Herblain, Nantes, France on 28 June 2010. The facility, located adjacent to its...
Read moreRoche Mustahzarlari has completed the construction of their pharmaceutical facility at Gebze, close to Istanbul, Turkey. The new drugs manufacturing...
Read moreQuintiles, a US-based biopharmaceutical services company, inaugurated its new research facility in London on 8 March 2010. Known as the...
Read moreNovo Nordisk is upgrading the insulin production plant at its facility in Chartres, Eure-et-Loir region, France. The Danish company is...
Read moreIndia-based contract manufacturer Kemwell launched a new solid and semi-solid pharmaceutical manufacturing facility in Sweden on 18 May 2010. Located...
Read moreMirapex (Pramipexole) is a medication indicated for Parkinson's disease (PD). Developed by Boehringer Ingelheim, Mirapex was approved by the US...
Read moreSelincro (nalmefene) is an injected drug for the treatment of alcohol dependence. The drug was originally developed by Key Pharmaceuticals...
Read moreWilate is a von Willebrand Factor/Coagulation Factor VIII (vWF/FVIII) concentrate developed for the treatment of von Willebrand disease (vWD). The...
Read moreZinforo (ceftaroline fosamil) is a new intravenous cephalosporin antibiotic indicated for the treatment of serious skin infections or community-acquired pneumonia....
Read moreGlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014. The new...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.